Simone Claudiani

504 total citations
31 papers, 209 citations indexed

About

Simone Claudiani is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Simone Claudiani has authored 31 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 23 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Simone Claudiani's work include Chronic Myeloid Leukemia Treatments (28 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Simone Claudiani is often cited by papers focused on Chronic Myeloid Leukemia Treatments (28 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Simone Claudiani collaborates with scholars based in United Kingdom, United States and Italy. Simone Claudiani's co-authors include Jane F. Apperley, Dragana Milojković, Jamshid S. Khorashad, Richard Szydlo, Andrew J. Innes, Letizia Foroni, Afzal Khan, Gareth Gerrard, Pierre Foskett and Georgios Nteliopoulos and has published in prestigious journals such as Nature Communications, Blood and British Journal of Haematology.

In The Last Decade

Simone Claudiani

30 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Claudiani United Kingdom 8 165 136 49 45 29 31 209
Peter Schuld Germany 7 138 0.8× 111 0.8× 54 1.1× 29 0.6× 22 0.8× 15 201
Daniela Žáčková Czechia 8 140 0.8× 109 0.8× 45 0.9× 40 0.9× 14 0.5× 34 175
Gioia Colafigli Italy 11 270 1.6× 178 1.3× 61 1.2× 54 1.2× 30 1.0× 41 333
A. Megan Cornelison United States 9 246 1.5× 144 1.1× 55 1.1× 52 1.2× 42 1.4× 16 324
Odoardo Maria Olimpieri Italy 8 105 0.6× 109 0.8× 50 1.0× 46 1.0× 16 0.6× 11 222
Cristina Bucelli Italy 9 173 1.0× 162 1.2× 73 1.5× 34 0.8× 6 0.2× 33 250
Christos Demosthenous Greece 8 77 0.5× 64 0.5× 12 0.2× 61 1.4× 21 0.7× 19 202
Tülin Tuğlular Türkiye 7 93 0.6× 87 0.6× 37 0.8× 18 0.4× 7 0.2× 25 174
Kristina Myhr‐Eriksson Sweden 7 160 1.0× 95 0.7× 45 0.9× 32 0.7× 29 1.0× 7 180
Véronique Bédoucha Switzerland 5 327 2.0× 271 2.0× 163 3.3× 79 1.8× 36 1.2× 13 349

Countries citing papers authored by Simone Claudiani

Since Specialization
Citations

This map shows the geographic impact of Simone Claudiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Claudiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Claudiani more than expected).

Fields of papers citing papers by Simone Claudiani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Claudiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Claudiani. The network helps show where Simone Claudiani may publish in the future.

Co-authorship network of co-authors of Simone Claudiani

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Claudiani. A scholar is included among the top collaborators of Simone Claudiani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Claudiani. Simone Claudiani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robertson, H, Dragana Milojković, Nauman M. Butt, et al.. (2024). Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy. British Journal of Haematology. 205(3). 947–955. 6 indexed citations
2.
Claudiani, Simone, Dragana Milojković, Andrew J. Innes, et al.. (2024). Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia. Leukemia & lymphoma. 65(8). 1161–1166. 3 indexed citations
3.
Claudiani, Simone, Afzal Khan, Jamshid S. Khorashad, et al.. (2024). Long-term outcomes after upfront second-generation tyrosine kinase inhibitors for chronic myeloid leukemia: managing intolerance and resistance. Leukemia. 38(4). 796–802. 7 indexed citations
4.
Andrés, María Sol, Simone Claudiani, Nazanin Zounemat Kermani, et al.. (2024). Cardiovascular events in CML patients treated with Nilotinib: validation of the HFA-ICOS baseline risk score. Cardio-Oncology. 10(1). 42–42. 3 indexed citations
5.
May, Philippa C., Alistair Reid, Mark E. Robinson, et al.. (2023). FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions. BMC Medical Genomics. 16(1). 172–172. 4 indexed citations
6.
Cook, Lucy, Dragana Milojković, Jane F. Apperley, et al.. (2022). Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies. Nature Communications. 13(1). 6922–6922. 8 indexed citations
7.
Dominy, Kathy, Simone Claudiani, Richard Szydlo, et al.. (2022). Assessment of quantitative polymerase chain reaction for BCR–ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?. British Journal of Haematology. 197(1). 52–62. 6 indexed citations
8.
Claudiani, Simone, Jane F. Apperley, Eleanor Parker, et al.. (2021). Durable humoral responses after the second anti‐SARS‐CoV‐2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors. British Journal of Haematology. 197(1). e1–e4. 10 indexed citations
9.
Laffan, Michael, et al.. (2020). Platelet function in patients with chronic myeloid leukemia treated with asciminib. Leukemia & lymphoma. 61(12). 3021–3023. 1 indexed citations
10.
Claudiani, Simone, Jane F. Apperley, Richard Szydlo, et al.. (2020). TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia. British Journal of Haematology. 193(2). 346–355. 23 indexed citations
11.
Claudiani, Simone, Carolina Rosadas, Myra O. McClure, et al.. (2020). Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia. Blood. 136(Supplement 1). 20–20. 8 indexed citations
12.
Mason, Clinton C., Michael Albert, Alistair Reid, et al.. (2020). Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy. British Journal of Haematology. 192(1). 137–145. 6 indexed citations
13.
Hanley, Brian, Simone Claudiani, Dragana Milojković, et al.. (2019). T-cell prolymphocytic leukaemia in a patient with chronic myeloid leukaemia receiving nilotinib: first documented report. Journal of Clinical Pathology. 72(7). 511–512.
14.
Claudiani, Simone, Silvia Metelli, Richard Szydlo, et al.. (2019). Introducing a Predictive Score for Successful Treatment Free Remission in Chronic Myeloid Leukemia (CML). Blood. 134(Supplement_1). 26–26. 8 indexed citations
15.
Nteliopoulos, Georgios, Alexandra Bazeos, Simone Claudiani, et al.. (2019). Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors. Haematologica. 104(12). 2400–2409. 36 indexed citations
16.
Claudiani, Simone, Aoife Gatenby, Richard Szydlo, et al.. (2019). MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia. Haematologica. 104(11). 2206–2214. 11 indexed citations
17.
Claudiani, Simone, Jane F. Apperley, Afzal Khan, Jamshid S. Khorashad, & Dragana Milojković. (2019). Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations. Haematologica. 105(5). e225–e227. 7 indexed citations
18.
Claudiani, Simone, Dragana Milojković, Richard Szydlo, et al.. (2017). Changes in RT-qPCR Levels during and after TKI Interruptions for Attempted Conceptions in Women with CML. Blood. 130. 1612. 1 indexed citations
19.
Apperley, Jane F., Jenny Byrne, Graeme Smith, et al.. (2016). The Real World Use of Bosutinib in Patients with Chronic Myeloid Leukaemia. Blood. 128(22). 5435–5435. 3 indexed citations
20.
Rivera, Victor M., Susan Branford, Franck E. Nicolini, et al.. (2015). A Multi-Institutional Retrospective Analysis of Tyrosine Kinase Inhibitor (TKI) Clinical and Preclinical Efficacy According to BCR-ABL Mutation Status in CP-CML Patients. Blood. 126(23). 2790–2790. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Schuld Breakdown of academic impact, for papers by Daniela Žáčková Breakdown of academic impact, for papers by Gioia Colafigli Breakdown of academic impact, for papers by A. Megan Cornelison Breakdown of academic impact, for papers by Odoardo Maria Olimpieri Breakdown of academic impact, for papers by Cristina Bucelli Breakdown of academic impact, for papers by Christos Demosthenous Breakdown of academic impact, for papers by Tülin Tuğlular Breakdown of academic impact, for papers by Kristina Myhr‐Eriksson Breakdown of academic impact, for papers by Véronique Bédoucha
Rankless by CCL
2026